Overview

  • Product nameAnti-c-Fos (phospho T232) antibody
    See all c-Fos primary antibodies
  • Description
    Rabbit polyclonal to c-Fos (phospho T232)
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Sheep, Pig, Chimpanzee
  • Immunogen

    Synthetic peptide conjugated to KLH derived from within residues 200 - 300 of Human c-Fos, phosphorylated at T232.

    (Peptide available as ab43652.)

  • Positive control
    • This antibody gave a positive signal in the following human whole cell lysates: A431 - EGF treated, HeLa, Hela - Bleomycin Treated (40U/ml), Hela - Hydroxyurea Treated (48hr, 2uM). This antibody also gave a positive signal against the Full length Recombinant FOS protein (Tagged).

Properties

Associated products

Applications

Our Abpromise guarantee covers the use of ab43175 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 1 µg/ml. Detects a band of approximately 95 kDa (predicted molecular weight: 41 kDa).

Target

  • FunctionNuclear phosphoprotein which forms a tight but non-covalently linked complex with the JUN/AP-1 transcription factor. In the heterodimer, FOS and JUN/AP-1 basic regions each seems to interact with symmetrical DNA half sites. On TGF-beta activation, forms a multimeric SMAD3/SMAD4/JUN/FOS complex at the AP1/SMAD-binding site to regulate TGF-beta-mediated signaling. Has a critical function in regulating the Has a critical function in regulating the development of cells destined to form and maintain the skeleton. It is thought to have an important role in signal transduction, cell proliferation and differentiation.
  • Sequence similaritiesBelongs to the bZIP family. Fos subfamily.
    Contains 1 bZIP domain.
  • Post-translational
    modifications
    Phosphorylated in the C-terminal upon stimulation by nerve growth factor (NGF) and epidermal growth factor (EGF). Phosphorylated, in vitro, by MAPK and RSK1. Phosphorylation on both Ser-362 and Ser-374 by MAPK1/2 and RSK1/2 leads to protein stabilization with phosphorylation on Ser-374 being the major site for protein stabilization on NGF stimulation. Phosphorylation on Ser-362 and Ser-374 primes further phosphorylations on Thr-325 and Thr-331 through promoting docking of MAPK to the DEF domain. Phosphorylation on Thr-232, induced by HA-RAS, activates the transcriptional activity and antagonizes sumoylation. Phosphorylation on Ser-362 by RSK2 in osteoblasts contributes to osteoblast transformation.
    Constitutively sumoylated by SUMO1, SUMO2 and SUMO3. Desumoylated by SENP2. Sumoylation requires heterodimerization with JUN and is enhanced by mitogen stimulation. Sumoylation inhibits the AP-1 transcriptional activity and is, itself, inhibited by Ras-activated phosphorylation on Thr-232.
  • Cellular localizationNucleus.
  • Information by UniProt
  • Database links
  • Alternative names
    • Activator protein 1 antibody
    • AP 1 antibody
    • C FOS antibody
    • Cellular oncogene c fos antibody
    • Cellular oncogene fos antibody
    • FBJ murine osteosarcoma viral (v fos) oncogene homolog (oncogene FOS) antibody
    • FBJ murine osteosarcoma viral oncogene homolog antibody
    • FBJ murine osteosarcoma viral v fos oncogene homolog antibody
    • FBJ Osteosarcoma Virus antibody
    • FOS antibody
    • FOS protein antibody
    • FOS_HUMAN antibody
    • G0 G1 switch regulatory protein 7 antibody
    • G0/G1 switch regulatory protein 7 antibody
    • G0S7 antibody
    • Oncogene FOS antibody
    • p55 antibody
    • proto oncogene c Fos antibody
    • Proto oncogene protein c fos antibody
    • Proto-oncogene c-Fos antibody
    • v fos FBJ murine osteosarcoma viral oncogene homolog antibody
    see all

Anti-c-Fos (phospho T232) antibody images

  • All lanes : Anti-c-Fos (phospho T232) antibody (ab43175) at 1 µg/ml

    Lane 1 : A431 (Human epithelial carcinoma cell line) Whole Cell Lysate - EGF treated
    Lane 2 : HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate
    Lane 3 : Hela Whole Cell Lysate - Bleomycin Treated (40U/ml)
    Lane 4 : Hela Whole Cell Lysate - Hydroxyurea Treated (48hr, 2uM)
    Lane 5 : A431 (Human epithelial carcinoma cell line) Whole Cell Lysate - EGF treated with Human c-Fos (phospho T232) peptide (ab43652) at 1 µg/ml
    Lane 6 : HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate with Human c-Fos (phospho T232) peptide (ab43652) at 1 µg/ml
    Lane 7 : Hela Whole Cell Lysate - Bleomycin Treated (40U/ml) with Human c-Fos (phospho T232) peptide (ab43652) at 1 µg/ml
    Lane 8 : Hela Whole Cell Lysate - Hydroxyurea Treated (48hr, 2uM) with Human c-Fos (phospho T232) peptide (ab43652) at 1 µg/ml
    Lane 9 : A431 (Human epithelial carcinoma cell line) Whole Cell Lysate - EGF treated with Human c-Fos peptide (ab60297) at 1 µg/ml
    Lane 10 : HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate with Human c-Fos peptide (ab60297) at 1 µg/ml
    Lane 11 : Hela Whole Cell Lysate - Bleomycin Treated (40U/ml) with Human c-Fos peptide (ab60297) at 1 µg/ml
    Lane 12 : Hela Whole Cell Lysate - Hydroxyurea Treated (48hr, 2uM) with Human c-Fos peptide (ab60297) at 1 µg/ml

    Lysates/proteins at 10 µg per lane.

    Secondary
    Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

    Performed under reducing conditions.

    Predicted band size : 41 kDa
    Observed band size : 95 kDa (why is the actual band size different from the predicted?)
  • Anti-c-Fos (phospho T232) antibody (ab43175) at 1 µg/ml + Recombinant Human c-Fos protein (ab56280) at 0.1 µg

    Secondary
    Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

    Performed under reducing conditions.

    Predicted band size : 41 kDa
    Observed band size : 78 kDa (why is the actual band size different from the predicted?)

References for Anti-c-Fos (phospho T232) antibody (ab43175)

This product has been referenced in:
  • Araújo FC  et al. Expression of the proto-oncogene c-fos and the immunolocalization of c-fos, phosphorylated c-fos and estrogen receptor beta in the human testis. Histol Histopathol 24:1515-22 (2009). IHC-P ; Human . Read more (PubMed: 19795350) »
  • Morsch DM  et al. c-fos gene and protein expression in pelvic endometriosis: a local marker of estrogen action. J Mol Histol 40:53-8 (2009). IHC-P ; Human . Read more (PubMed: 19199093) »

See all 2 Publications for this product

Product Wall

There are currently no Abreviews or Questions for ab43175.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"